Repression of the IgH enhancer in teratocarcinoma cells associated with a novel octamer factor.

Embryonal carcinoma (EC) cell lines are models for early cells in mouse embryogenesis. A 300-base pair fragment of the heavy chain enhancer was inactive in F9 EC cells, unlike in other nonlymphoid cells where it has significant activity. Alterations of the octamer motif increased enhancer activity. Nuclear extracts from F9 cells contained an octamer binding protein (NF-A3) that was unique to EC cells; the amount of NF-A3 decreased upon differentiation. It is proposed that NF-A3 represses specific regulatory sequences that contain the octamer motif. Thus, the same DNA sequence mediates either negative or positive transcriptional effects, depending on the cell type.

[1]  F. Fujimura,et al.  Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells , 1988, Journal of virology.

[2]  P. Sharp,et al.  Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. , 1988, Science.

[3]  J. Perez-Mutul,et al.  Mutational analysis of the contribution of sequence motifs within the IgH enhancer to tissue specific transcriptional activation , 1988, Nucleic Acids Res..

[4]  L. Su,et al.  Identification and characterization of two functional domains within the murine heavy-chain enhancer , 1988, Molecular and cellular biology.

[5]  N. Heintz,et al.  Purification and characterization of OTF-1, a transcription factor regulating cell cycle expression of a human histone H2b gene , 1987, Cell.

[6]  A. Heguy,et al.  Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro , 1987, Cell.

[7]  L. Staudt,et al.  An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity , 1987, Nature.

[8]  G. Superti-Furga,et al.  Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter , 1987, Cell.

[9]  J. Nevins,et al.  A factor discriminating between the wildtype and a mutant polyomavirus enhancer , 1987, Nature.

[10]  D. Baltimore,et al.  Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. , 1987, Science.

[11]  K. Yamamoto,et al.  The immunoglobulin octanucleotide: independent activity and selective interaction with enhancers. , 1987, Science.

[12]  W. Schaffner,et al.  The SV40 enhancer can be dissected into multiple segments, each with a different cell type specificity. , 1987, Genes & development.

[13]  A. Bothwell,et al.  Mutational analysis of the immunoglobulin heavy chain promoter region. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Sharp,et al.  A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes , 1986, Nature.

[15]  P. Tucker,et al.  Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences , 1986, Nature.

[16]  P. Chambon,et al.  Cell-type specific protein binding to the enhancer of simian virus 40 in nuclear extracts , 1986, Nature.

[17]  T. Kadesch,et al.  Functional analysis of the murine IgH enhancer: evidence for negative control of cell-type specificity. , 1986, Nucleic acids research.

[18]  R. Roeder,et al.  Interaction of a common factor with conserved promoter and enhancer sequences in histone H2B, immunoglobulin, and U2 small nuclear RNA (snRNA) genes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  P. Chambon,et al.  A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products , 1986, Nature.

[20]  P. Sharp,et al.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes , 1986, Nature.

[21]  P. Rigby,et al.  Negative regulation of viral enhancers in undifferentiated embryonic stem cells , 1985, Cell.

[22]  T. Vogt,et al.  Tissue-specific activation of a cloned α-fetoprotein gene during differentiation of a transfected embryonal carcinoma cell line , 1984, Nature.

[23]  P Berg,et al.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. , 1982, Journal of molecular and applied genetics.

[24]  S. Strickland,et al.  Hormonal induction of differentiation in teratocarcinoma stem cells: Generation of parietal endoderm by retinoic acid and dibutyryl cAMP , 1980, Cell.

[25]  S. Strickland,et al.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid , 1978, Cell.

[26]  G. Martin,et al.  Teratocarcinomas as a model system for the study of embryogenesis and neoplasia , 1975, Cell.